AI-designed Affinity Reagents
We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.
What they do:
Engineering a future without cancer deaths.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Patient Intelligence Platform for Genetic Disease
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Cancer Diagnosis 10X faster, 10X cheaper
Quick facts:
HQ: Durham, NC, United States
What they do:
Gen-AI Designed Enzymes for Pharmaceutical Innovation
Quick facts:
HQ: Boston, MA, United States
What they do:
First ECG AI to go beyond diagnostics and recommend treatment
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Redefining the Standard of Care for Iron Deficiency Anemia
Quick facts:
HQ: San Francisco, CA, United States
AI-designed Affinity Reagents
Austin, TX, United States
6 employees, according to the company profile.
There are no funding rounds for Medium Biosciences in our data.
Similar startups: Numen, Probably Genetic, and Data Driven Bioscience.